Procaspase Activating Compound-1 (PAC-1) in the Treatment of Advanced Malignancies - Component 1
Clinical trial NCT02355535 · COMPLETED
Trial details
- NCT number
- NCT02355535
- Sponsor
- Vanquish Oncology, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-02-01
- Primary completion
- 2020-05-18
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.